Literature DB >> 26297513

Investigating the underlying mechanisms of aberrant behaviors in bipolar disorder from patients to models: Rodent and human studies.

Jordy van Enkhuizen1, Mark A Geyer2, Arpi Minassian3, William Perry3, Brook L Henry3, Jared W Young4.   

Abstract

Psychiatric patients with bipolar disorder suffer from states of depression and mania, during which a variety of symptoms are present. Current treatments are limited and neurocognitive deficits in particular often remain untreated. Targeted therapies based on the biological mechanisms of bipolar disorder could fill this gap and benefit patients and their families. Developing targeted therapies would benefit from appropriate animal models which are challenging to establish, but remain a vital tool. In this review, we summarize approaches to create a valid model relevant to bipolar disorder. We focus on studies that use translational tests of multivariate exploratory behavior, sensorimotor gating, decision-making under risk, and attentional functioning to discover profiles that are consistent between patients and rodent models. Using this battery of translational tests, similar behavior profiles in bipolar mania patients and mice with reduced dopamine transporter activity have been identified. Future investigations should combine other animal models that are biologically relevant to the neuropsychiatric disorder with translational behavioral assessment as outlined here. This methodology can be utilized to develop novel targeted therapies that relieve symptoms for more patients without common side effects caused by current treatments.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Animal model; Bipolar disorder; Dopamine transporter; Translational

Mesh:

Year:  2015        PMID: 26297513      PMCID: PMC4684462          DOI: 10.1016/j.neubiorev.2015.08.008

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  180 in total

1.  Effects of topiramate on the prepulse inhibition of the acoustic startle in rats.

Authors:  Roberto Frau; Marco Orrù; Mauro Fà; Alberto Casti; Mario Manunta; Nicola Fais; Giampaolo Mereu; Gianluigi Gessa; Marco Bortolato
Journal:  Neuropsychopharmacology       Date:  2006-06-14       Impact factor: 7.853

2.  Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder.

Authors:  I J Torres; C M DeFreitas; V G DeFreitas; D J Bond; M Kunz; W G Honer; R W Lam; L N Yatham
Journal:  Psychol Med       Date:  2011-05       Impact factor: 7.723

3.  The amphetamine-chlordiazepoxide mixture, a pharmacological screen for mood stabilizers, does not enhance amphetamine-induced disruption of prepulse inhibition.

Authors:  Tessa N Douma; Adam Kolarz; Ynte Postma; Berend Olivier; Lucianne Groenink
Journal:  Behav Brain Res       Date:  2011-07-26       Impact factor: 3.332

4.  Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.

Authors:  Jared W Young; Jordy van Enkhuizen; Catharine A Winstanley; Mark A Geyer
Journal:  J Psychopharmacol       Date:  2011-03-18       Impact factor: 4.153

5.  Valproate attenuates hyperactive and perseverative behaviors in mutant mice with a dysregulated dopamine system.

Authors:  Rebecca J Ralph-Williams; Martin P Paulus; Xiaoxi Zhuang; Rene Hen; Mark A Geyer
Journal:  Biol Psychiatry       Date:  2003-02-15       Impact factor: 13.382

Review 6.  The neurobiology of the switch process in bipolar disorder: a review.

Authors:  Giacomo Salvadore; Jorge A Quiroz; Rodrigo Machado-Vieira; Ioline D Henter; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-05-04       Impact factor: 4.384

Review 7.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 8.  Reverse translational strategies for developing animal models of bipolar disorder.

Authors:  Oz Malkesman; Daniel R Austin; Guang Chen; Husseini K Manji
Journal:  Dis Model Mech       Date:  2009 May-Jun       Impact factor: 5.758

9.  Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder.

Authors:  Anabel Martínez-Arán; Eduard Vieta; María Reinares; Francesc Colom; Carla Torrent; Jose Sánchez-Moreno; Antonio Benabarre; José Manuel Goikolea; Mercè Comes; Manel Salamero
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

10.  Reverse translation of the rodent 5C-CPT reveals that the impaired attention of people with schizophrenia is similar to scopolamine-induced deficits in mice.

Authors:  J W Young; M A Geyer; A J Rissling; R F Sharp; L T Eyler; G L Asgaard; G A Light
Journal:  Transl Psychiatry       Date:  2013-11-12       Impact factor: 6.222

View more
  10 in total

Review 1.  Identity in bipolar disorder: Self-worth and achievement.

Authors:  Manon L Ironside; Sheri L Johnson; Charles S Carver
Journal:  J Pers       Date:  2019-02-13

2.  Abnormal Functional Relationship of Sensorimotor Network With Neurotransmitter-Related Nuclei via Subcortical-Cortical Loops in Manic and Depressive Phases of Bipolar Disorder.

Authors:  Matteo Martino; Paola Magioncalda; Benedetta Conio; Laura Capobianco; Daniel Russo; Giulia Adavastro; Shankar Tumati; Zhonglin Tan; Hsin-Chien Lee; Timothy J Lane; Mario Amore; Matilde Inglese; Georg Northoff
Journal:  Schizophr Bull       Date:  2020-01-04       Impact factor: 9.306

3.  Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers.

Authors:  Andrea L Pappas; Alexandra L Bey; Xiaoming Wang; Mark Rossi; Yong Ho Kim; Haidun Yan; Fiona Porkka; Lara J Duffney; Samantha M Phillips; Xinyu Cao; Jin-Dong Ding; Ramona M Rodriguiz; Henry H Yin; Richard J Weinberg; Ru-Rong Ji; William C Wetsel; Yong-Hui Jiang
Journal:  JCI Insight       Date:  2017-10-19

4.  Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania.

Authors:  Morgane Milienne-Petiot; Mark A Geyer; Jørn Arnt; Jared W Young
Journal:  Psychopharmacology (Berl)       Date:  2017-02-03       Impact factor: 4.530

Review 5.  Phenotypes, mechanisms and therapeutics: insights from bipolar disorder GWAS findings.

Authors:  Ming Li; Tao Li; Xiao Xiao; Jun Chen; Zhonghua Hu; Yiru Fang
Journal:  Mol Psychiatry       Date:  2022-03-29       Impact factor: 15.992

Review 6.  The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species.

Authors:  Savita G Bhakta; Jared W Young
Journal:  J Neurosci Methods       Date:  2017-07-25       Impact factor: 2.390

Review 7.  A unified model of the pathophysiology of bipolar disorder.

Authors:  Paola Magioncalda; Matteo Martino
Journal:  Mol Psychiatry       Date:  2021-04-15       Impact factor: 15.992

Review 8.  Tracing the psychopathology of bipolar disorder to the functional architecture of intrinsic brain activity and its neurotransmitter modulation: a three-dimensional model.

Authors:  Matteo Martino; Paola Magioncalda
Journal:  Mol Psychiatry       Date:  2021-01-07       Impact factor: 15.992

Review 9.  Circadian Mechanisms Underlying Reward-Related Neurophysiology and Synaptic Plasticity.

Authors:  Puja K Parekh; Colleen A McClung
Journal:  Front Psychiatry       Date:  2016-01-12       Impact factor: 4.157

Review 10.  Animal models for bipolar disorder: from bedside to the cage.

Authors:  Dominik K E Beyer; Nadja Freund
Journal:  Int J Bipolar Disord       Date:  2017-10-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.